-
Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment.
Am J Pathol. 2004 Feb;164(2):457-66
PMID: 14742252
-
SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion.
Cancer Lett. 2006 May 8;236(1):39-45
PMID: 15967572
-
Culture of vascular endothelium.
Prog Hemost Thromb. 1976;3:1-28
PMID: 181786
-
The biology of VEGF and its receptors.
Nat Med. 2003 Jun;9(6):669-76
PMID: 12778165
-
Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1.
Nat Med. 2003 Jul;9(7):936-43
PMID: 12796773
-
VEGF-A(164/165) and PlGF: roles in angiogenesis and arteriogenesis.
Trends Cardiovasc Med. 2003 Jul;13(5):169-75
PMID: 12837578
-
Melanoma-associated expression of vascular endothelial growth factor and its receptors FLT-1 and KDR.
J Cancer Res Clin Oncol. 1999 Nov;125(11):621-9
PMID: 10541969
-
Placenta growth factor is induced in human keratinocytes during wound healing.
J Invest Dermatol. 2000 Sep;115(3):388-95
PMID: 10951273
-
Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor.
J Invest Dermatol. 2000 Dec;115(6):1000-7
PMID: 11121133
-
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.
Nat Med. 2001 May;7(5):575-83
PMID: 11329059
-
Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1.
Ann N Y Acad Sci. 2001 Jun;938:36-45; discussion 45-7
PMID: 11458524
-
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth.
Nat Med. 2001 Nov;7(11):1194-201
PMID: 11689883
-
Placental growth factor is a survival factor for tumor endothelial cells and macrophages.
Cancer Res. 2002 May 15;62(10):2749-52
PMID: 12019148
-
Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability.
J Cell Sci. 2002 Jun 15;115(Pt 12):2559-67
PMID: 12045226
-
Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers.
Cancer Cell. 2002 Feb;1(1):99-108
PMID: 12086892
-
Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.
Nat Med. 2002 Aug;8(8):831-40
PMID: 12091877
-
Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment.
Nat Med. 2002 Aug;8(8):841-9
PMID: 12091880
-
Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice.
J Natl Cancer Inst. 2002 Aug 7;94(15):1134-42
PMID: 12165638
-
MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis.
Cancer Cell. 2002 Oct;2(4):289-300
PMID: 12398893
-
Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: potential relationship to post-therapy tumor angiogenesis and recurrence.
Int J Cancer. 2003 Jun 10;105(2):158-64
PMID: 12673673
-
Vascular endothelial growth factor receptor-1 is deposited in the extracellular matrix by endothelial cells and is a ligand for the alpha 5 beta 1 integrin.
J Cell Sci. 2003 Sep 1;116(Pt 17):3479-89
PMID: 12865438
-
Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation.
Cancer Res. 2003 Dec 1;63(23):8221-5
PMID: 14678978
-
Ehlers-Danlos syndrome type VIIB. Deletion of 18 amino acids comprising the N-telopeptide region of a pro-alpha 2(I) chain.
J Biol Chem. 1987 Dec 5;262(34):16376-85
PMID: 3680255
-
New colorimetric cytotoxicity assay for anticancer-drug screening.
J Natl Cancer Inst. 1990 Jul 4;82(13):1107-12
PMID: 2359136
-
Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors.
Biochem Biophys Res Commun. 1993 Feb 15;190(3):702-8
PMID: 8439321
-
Vascular endothelial growth factor and its receptors.
Prog Growth Factor Res. 1994;5(1):89-97
PMID: 7515293
-
Purification and characterization of a naturally occurring vascular endothelial growth factor.placenta growth factor heterodimer.
J Biol Chem. 1995 Mar 31;270(13):7717-23
PMID: 7706320
-
Endothelial cell-to-cell junctions.
FASEB J. 1995 Jul;9(10):910-8
PMID: 7615160
-
Angiogenesis in cancer, vascular, rheumatoid and other disease.
Nat Med. 1995 Jan;1(1):27-31
PMID: 7584949
-
The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis.
J Biol Chem. 1996 Jul 26;271(30):17629-34
PMID: 8663424
-
In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor.
J Clin Invest. 1996 Dec 1;98(11):2507-11
PMID: 8958213
-
Placenta growth factor is abundantly expressed in human cervical squamous cell carcinoma.
Eur J Gynaecol Oncol. 1997;18(6):508-10
PMID: 9443023
-
Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.
Cancer Res. 1998 Mar 1;58(5):1048-51
PMID: 9500469
-
VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer.
Am J Pathol. 1999 May;154(5):1381-90
PMID: 10329591
-
Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.
Science. 1999 Jun 18;284(5422):1994-8
PMID: 10373119
-
Expression and localization of placenta growth factor and PlGF receptors in human meningiomas.
J Pathol. 1999 Sep;189(1):66-71
PMID: 10451490
-
Vascularization of melanoma by mobilization and remodeling of preexisting latent vessels to patency.
Cancer Res. 2005 Feb 1;65(3):913-8
PMID: 15705890
-
Metalloproteinases and their inhibitors in tumor angiogenesis.
Int J Cancer. 2005 Jul 20;115(6):849-60
PMID: 15729716
-
An autocrine loop directed by the vascular endothelial growth factor promotes invasiveness of human melanoma cells.
Int J Oncol. 2005 Dec;27(6):1625-32
PMID: 16273219
-
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche.
Nature. 2005 Dec 8;438(7069):820-7
PMID: 16341007
-
VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells.
Cell. 2006 Jan 13;124(1):175-89
PMID: 16413490
-
Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulation.
Blood. 2004 Apr 15;103(8):2942-9
PMID: 15070669